EMR3 is an Orphan-B GPCR with an unknown ligand. Two variants are produced by alternative splicing. One form encodes a 652-amino acid GPCR consisting of two EGF-like domains and a mucin stalk, while the other is a truncated soluble form containing only two EGF-like domains. EMR3 and EMR2 share a high degree of sequence identity in the transmembrane domains.
Immunogen
EMR3 antibody was raised against a peptide located in the C-Terminal cytoplasmic domain of EMR3 (Human).
Key Feature
Clonality
Polyclonal
Host Species
Rabbit
Tested Applications
ELISAIHC
EMR3 antibody can be used in immunohistochemistry starting at 5 μg/mL.: